GSK3β is involved in canonical signalling pathways and cancer progression as a tumor suppressor; however, it also functions as an oncogene to accelerate tumor growth in pancreatic and colorectal cancer [46] and hepatocellular carcinoma [47]. This evidence concerns the gene GSK3B and hepatocellular carcinoma.